Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Array Biopharma, Inc.
(NQ:
ARRY
)
5.020
USD
+0.060 (+1.21%)
Streaming Delayed Price
/ Updated:
11:00 AM EDT, Jun 19, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Press releases about Array Biopharma, Inc.
< Previous
1
2
3
4
5
6
7
8
9
Next >
MEK162 Shows Promising Clinical Activity in Ongoing Phase 2 Trial
June 04, 2012
from
Business Wire News Releases
Array BioPharma to Present at the Jefferies 2012 Global Healthcare Conference
May 30, 2012
from
Business Wire News Releases
Array BioPharma Announces Clinical Data Presentations at the 2012 ASCO Annual Meeting
May 16, 2012
from
Business Wire News Releases
Array BioPharma and Genentech's Strategic Alliance Voted Breakthrough Alliance of 2012
May 14, 2012
from
Business Wire News Releases
Array BioPharma Reports Financial Results for the Third Quarter of Fiscal 2012
April 30, 2012
from
Business Wire News Releases
Array BioPharma Names Liam Ratcliffe, M.D., Ph.D., to Board of Directors
April 30, 2012
from
Business Wire News Releases
Array BioPharma Names Ron Squarer Chief Executive Officer
April 26, 2012
from
Business Wire News Releases
Array BioPharma to Report Financial Results for the Third Quarter of Fiscal 2012 on April 30, 2012
April 23, 2012
from
Business Wire News Releases
Array BioPharma Names Howard Holden, Ph.D., Vice President of Regulatory Affairs and Quality Assurance
April 16, 2012
from
Business Wire News Releases
Encouraging Selumetinib Results Announced for Phase 2 Trial in Ovarian Cancer
April 04, 2012
from
Business Wire News Releases
Foundation Medicine Announces Collaboration with Array BioPharma
March 06, 2012
from
Business Wire News Releases
Array BioPharma to Present at the Cowen and Company 32nd Annual Health Care Conference
February 27, 2012
from
Business Wire News Releases
Array BioPharma Announces Closing of Public Offering of Common Stock and Exercise of Overallotment Option
February 14, 2012
from
Business Wire News Releases
Array BioPharma to Present at the Leerink Swann Global Healthcare Conference
February 09, 2012
from
Business Wire News Releases
Array BioPharma Announces Proposed Public Offering of Common Stock
February 09, 2012
from
Business Wire News Releases
Array BioPharma Announces Proposed Public Offering of Common Stock
February 08, 2012
from
Business Wire News Releases
Array BioPharma Names Gwen A. Fyfe, M.D. to Board of Directors
January 30, 2012
from
Business Wire News Releases
Array BioPharma Reports Financial Results for the Second Quarter of Fiscal 2012
January 30, 2012
from
Business Wire News Releases
Array BioPharma to Report Financial Results for the Second Quarter of Fiscal 2012 on January 30, 2012
January 23, 2012
from
Business Wire News Releases
Array BioPharma's Chief Executive Officer Robert E. Conway Resigns
January 16, 2012
from
Business Wire News Releases
Array BioPharma to Present at the 30th Annual J.P. Morgan Healthcare Conference
January 04, 2012
from
Business Wire News Releases
ARRY-614 Demonstrates Positive Single Agent Activity in Patients with Myelodysplastic Syndromes
December 11, 2011
from
Business Wire News Releases
ARRY-520 Demonstrates Durable Single-Agent Activity in Patients with Advanced Multiple Myeloma
December 11, 2011
from
Business Wire News Releases
Array BioPharma to Host Analyst and Investor Day Featuring Distinguished Clinical Investigators
December 01, 2011
from
Business Wire News Releases
Array Biopharma to Present Clinical Data on ARRY-520, a KSP Inhibitor, and ARRY-614, a Dual p38/Tie2 Inhibitor, at the 2011 American Society of Hematology Annual Meeting
November 29, 2011
from
Business Wire News Releases
Array BioPharma to Present at the Piper Jaffray Health Care Conference
November 17, 2011
from
Business Wire News Releases
Array BioPharma Reports Financial Results for the First Quarter of Fiscal 2012
October 31, 2011
from
Business Wire News Releases
Array BioPharma to Report Financial Results for the First Quarter of Fiscal 2012 on October 31, 2011
October 24, 2011
from
Business Wire News Releases
Topline Results: A Randomized Phase 2 Study of Selumetinib in Patients with KRAS-Mutant Non-Small Cell Lung Cancer
September 30, 2011
from
Business Wire News Releases
Array BioPharma to Present at the UBS Global Life Sciences Conference
September 12, 2011
from
Business Wire News Releases
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here